Início › Glioblastoma › Minnesota › Rochester
Ensaios clínicos de Glioblastoma em Rochester, MN
15 estudos para Glioblastoma estão buscando participantes em locais em Rochester e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RecrutandoFase 1/2
- Mayo Clinic in Rochester, Rochester
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
RecrutandoFase 2
- Mayo Clinic in Rochester, Rochester
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecrutandoFase 3
- Mayo Clinic - Rochester, Rochester
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
RecrutandoFase 1 inicial
- Mayo Clinic in Rochester, Rochester
Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
Recrutando
- Mayo Clinic in Rochester, Rochester
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Recrutando
- Mayo Clinic in Rochester, Rochester
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
Recrutando
- Mayo Clinic in Rochester, Rochester
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
RecrutandoFase 2
- Mayo Clinic, Rochester
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
RecrutandoFase 1/2
- Mayo Clinic in Rochester, Rochester
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
RecrutandoFase 1/2
- Mayo Clinic, Rochester
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
RecrutandoFase 1
- Mayo Clinic in Rochester, Rochester
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
RecrutandoFase 1/2
- Mayo Clinic Hospital, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecrutandoFase 1/2
- Mayo Clinic Cancer Center, Rochester
Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
RecrutandoFase 2
- Mayo Clinic, Rochester
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
RecrutandoFase 2
- Mayo Clinic, Rochester
Ensaios de Glioblastoma em outras cidades
- New York City, NY30 estudos
- Boston, MA28 estudos
- Houston, TX25 estudos
- Los Angeles, CA23 estudos
- Durham, NC20 estudos
- San Francisco, CA17 estudos
- Washington, DC15 estudos
- Chicago, IL15 estudos
- Columbus, OH14 estudos
- Miami, FL14 estudos
- Jacksonville, FL13 estudos
- Aurora, CO12 estudos
Outros estudos em Rochester
- Câncer de Mama42 estudos
- Câncer de Pulmão de Não Pequenas Células37 estudos
- Câncer Metastático31 estudos
- Câncer (todos os tipos)30 estudos
- Câncer Colorretal29 estudos
- Câncer de Ovário29 estudos
- Mieloma Múltiplo24 estudos
- Câncer de Próstata22 estudos
- Insuficiência Cardíaca22 estudos
- Câncer de Pâncreas22 estudos
- Câncer de Pulmão20 estudos
- Câncer Endometrial20 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.